RNA-Based Therapy to Increase Energy Expenditure & Promote Quality Body Weight Loss, Preserving Lean Mass
- RES-101, a first-in-class miR-22 inhibitor, restores lipid biosynthesis and drives adipose browning for sustained reduction of unhealthy fat and improved body composition
- Disease-modifying approach that can be synergistically combined with other therapeutic modalities
- Selectively addressing excess of adiposity to promote high quality body weight loss